Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CAREGEN CO., LTD.”

57 pharma patents match "CAREGEN CO., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 57
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 57 pharmaceutical patents matching "CAREGEN CO., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

57 results for “CAREGEN CO., LTD.” · 30,257 patents in full index Clear search

  1. US 10925923

    Peptide having anti-inflammatory activity, and use thereof

    CAREGEN CO., LTD. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  2. US 10874709

    Conjugate of salicylic acid and peptide

    CAREGEN CO., LTD. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  3. US 10865226

    Peptide showing melanogenesis promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  4. US 10738081

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  5. US 10723777

    Peptide having anti-obesity and anti-diabetes efficacy and use thereof

    CAREGEN CO., LTD. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  6. US 10695279

    Peptide having skin-whitening activity and use thereof

    CAREGEN CO., LTD. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  7. US 10669312

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  8. US 10626145

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  9. US 10568828

    Peptide having hair growth-promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  10. US 10526373

    Peptide showing melanin generation-promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  11. US 10508140

    Peptide having hair growth-promoting activity and/or melanin generation-promoting activity, and use thereof

    CAREGEN CO., LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  12. US 10487113

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  13. US 10351598

    Peptide with anti-obesity and anti-diabetic efficacy and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  14. US 10351597

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  15. US 10344061

    Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  16. US 10238710

    Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same

    CAREGEN CO., LTD. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted
  17. US 10093698

    Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same

    CAREGEN CO., LTD. · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  18. US 10080775

    Peptide having skin whitening activity, and use thereof

    CAREGEN CO., LTD. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  19. US 10047125

    Peptide having activity to improve skin condition and use thereof

    CAREGEN CO., LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  20. US 10000534

    Peptide having osteoblast proliferation activity and periodontal ligament fibroblast proliferation activity, and use of same

    CAREGEN CO., LTD. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  21. US 9908916

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  22. US 9637519

    Peptide for inducing mast cell-specific apoptosis and use thereof

    CAREGEN CO., LTD. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  23. US 9550078

    EDAR ligand derived peptides and use thereof

    CAREGEN CO., LTD. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  24. US 9303064

    Peptide inhibiting matrix metalloproteanases activity and use thereof

    CAREGEN CO., LTD. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted